Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Ulla Jeppesen"'
Publikováno v:
BMC Health Services Research, Vol 17, Iss 1, Pp 1-7 (2017)
Abstract Background High coverage of a screening program is essential to program success. Many European screening programs cover only 10–80% of their target population. A possible explanation for the low coverage may be that some women in the scree
Externí odkaz:
https://doaj.org/article/aecfc8d659ba42d09c786675e8a25d81
Publikováno v:
European Journal of Obstetrics & Gynecology and Reproductive Biology. 270:1-5
To investigate the risk of venous thromboembolism (VTE) in Danish women operated within a day surgery setting and to evaluate whether the current use of thromboprophylaxis without using graduated elastic compression stockings (GCS) is an appropriate
Autor:
Berit Andersen, Hans Svanholm, Anne Marie Schak Jensen, Tonje Johansen, Ulla Jeppesen, Sisse Helle Njor
Publikováno v:
Andersen, B, Njor, S H, Jensen, A M S, Johansen, T, Jeppesen, U & Svanholm, H 2020, ' HrHPV testing vs liquid-based cytology in cervical cancer screening among women aged 50 and older : A prospective study ', International Journal of Gynecological Cancer, vol. 30, no. 11, pp. 1678-1683 . https://doi.org/10.1136/ijgc-2020-001457
International Journal of Gynecological Cancer
International Journal of Gynecological Cancer
IntroductionEvidence supports high-risk human papilloma virus (HPV) testing as the primary cervical cancer screening tool. However, benefits and harms should be carefully considered before replacing liquid-based cytology. In women age 50 and older, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99e7ce12a41b1ecdad56d47d2cb2519b
https://pure.au.dk/portal/da/publications/hrhpv-testing-vs-liquidbased-cytology-in-cervical-cancer-screening-among-women-aged-50-and-older(0498fe86-56bd-472b-a019-e2785e4086e9).html
https://pure.au.dk/portal/da/publications/hrhpv-testing-vs-liquidbased-cytology-in-cervical-cancer-screening-among-women-aged-50-and-older(0498fe86-56bd-472b-a019-e2785e4086e9).html
Publikováno v:
Acta Obstetricia et Gynecologica Scandinavica.
Publikováno v:
Boie, S, Bor, I P & Jeppesen, U 2012, ' Begrænset effekt af bækkenbundstræning på genital prolaps ' Ugeskr. f. Læger, bind 173, nr. 50, s. 3256-59 .
Aarhus University
Aarhus University
A growing number of women are bothered by genital prolapse. The treatment of genital prolapse includes pelvic floor exercise in variable extent, but only few data are published. Variations in interventions, follow-up time, outcome etc. complicates a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::17a7455d522e7c5ff769abd6185eb460
https://pure.au.dk/portal/da/publications/begraenset-effekt-af-baekkenbundstraening-paa-genital-prolaps(e54027d9-33ec-4d28-8c8e-c15c824ee28a).html
https://pure.au.dk/portal/da/publications/begraenset-effekt-af-baekkenbundstraening-paa-genital-prolaps(e54027d9-33ec-4d28-8c8e-c15c824ee28a).html
Publikováno v:
Boie, S, Jeppesen, U & Bor, I P 2012, ' Limited evidence of the effect of prophylactic pelvic floor training on genital prolapse ', Bergen, Norway, 16/06/2012-19/06/2012, .
Aarhus University
Aarhus University
A growing number of women are bothered by genital prolapse. The treatment of genital prolapse includes pelvic floor exercise in variable extent, but only few data are published. Variations in interventions, follow-up time, outcome etc. complicates a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::5afb3c85c563883a33ec91e8c9558d0c
https://pure.au.dk/portal/da/publications/limited-evidence-of-the-effect-of-prophylactic-pelvic-floor-training-on-genital-prolapse(312eb91f-f74a-4ef6-84f5-b146a5576e45).html
https://pure.au.dk/portal/da/publications/limited-evidence-of-the-effect-of-prophylactic-pelvic-floor-training-on-genital-prolapse(312eb91f-f74a-4ef6-84f5-b146a5576e45).html
Autor:
Jens D Pagel, Ingrid Thranov, Anette Lykke Petri, Susanne K. Kjaer, Claus Høgdall, Ib Jarle Christensen, Estrid Høgdall, Berit Jul Mosgaard, Ulla Jeppesen, Line Stilling, Jan Blaakær
Publikováno v:
Petri, A L, Kjaer, S K, Christensen, I J, Blaakaer, J, Hogdall, E, Jeppesen, U, Mosgaard, B J, Pagel, J D, Stilling, L, Thranov, I & Hogdall, C 2009, ' Validation of epithelial ovarian cancer and fallopian tube cancer and ovarian borderline tumor data in the Danish Gynecological Cancer Database ', Acta Obstetricia et Gynecologica Scandinavica, vol. 88, no. 5, pp. 536-42 . https://doi.org/10.1080/00016340902846064
Udgivelsesdato: 2009-null OBJECTIVE: To validate the data on epithelial ovarian cancer, fallopian tube cancer and borderline ovarian tumors registered in the nationwide Danish Gynecological Cancer Database (DGCD) in 2005 and 2006. The DGCD is a multi
Autor:
Marianne Waldstrøm, Karina Dahl Steffensen, Anders Jakobsen, Ivan Brandslund, Hans Jørgen Knudsen, Ulla Jeppesen
Publikováno v:
Dahl Steffensen, K, Waldstrøm, M, Jeppesen, U, Knudsen, H J, Brandslund, I & Jakobsen, A 2008, ' Preoperative serum levels of epidermal growth factor receptor, HER2, and vascular endothelial growth factor in malignant and benign ovarian tumors ', Clinical Ovarian and Other Gynecologic Cancer, vol. 1, no. 2, pp. 127-134 . https://doi.org/10.3816/COC.2008.014
Background: Epidermal growth factor receptors ([EGFRs]; EGFR/HER1 and ErbB2/HER2) and vascular endothelial growth factor (VEGF) are essential to tumor growth and angiogenesis. The aim of the present study was to investigate the serum levels of these
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92491da2f9f6d6c9e58b9b35b792a525
https://portal.findresearcher.sdu.dk/da/publications/6f4e956e-f2d7-4dd6-8671-716f745f8244
https://portal.findresearcher.sdu.dk/da/publications/6f4e956e-f2d7-4dd6-8671-716f745f8244
Autor:
Karen Axelgaard Lorentzen, Karina Dahl Steffensen, Hans Jørgen Knudsen, Dorte Aalund Olsen, Ivan Brandslund, Thomas J. Corydon, Anders Jakobsen, Ulla Jeppesen, Marianne Waldstrøm
Publikováno v:
Steffensen, K D, Waldstrøm, M, Olsen, D A, Corydon, T, Lorentzen, K A, Knudsen, H J, Jeppesen, U, Brandslund, I & Jakobsen, A 2008, ' Mutant epidermal growth factor receptor in benign, borderline, and malignant ovarian tumors ', Clinical Cancer Research, vol. 14, no. 11, pp. 3278-3282 . https://doi.org/10.1158/1078-0432.CCR-07-4171
Steffensen, K D, Waldstrøm, M, Olsen, D A, Corydon, T, Lorentzen, K A, Knudsen, H J, Jeppesen, U, Brandslund, I & Jakobsen, A 2008, ' Mutant epidermal growth factor receptor in benign, borderline, and malignant ovarian tumors ', Clinical Cancer Research, vol. 14, no. 11, pp. 3278-82 . https://doi.org/10.1158/1078-0432.CCR-07-4171
Steffensen, K D, Waldstrøm, M, Olsen, D A, Corydon, T, Lorentzen, K A, Knudsen, H J, Jeppesen, U, Brandslund, I & Jakobsen, A 2008, ' Mutant epidermal growth factor receptor in benign, borderline, and malignant ovarian tumors ', Clinical Cancer Research, vol. 14, no. 11, pp. 3278-82 . https://doi.org/10.1158/1078-0432.CCR-07-4171
Purpose: Dysfunction of the epidermal growth factor (EGF) complex is essential to the growth and development of many human tumors. Overexpression of the EGF receptor (EGFR) is a characteristic finding in a considerable number of solid tumors and ofte
Autor:
Ulla, Jeppesen
Publikováno v:
Ugeskrift for laeger. 169(10)